• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种自动化和高通量的 UHPLC/MS 工作流程,用于药物制造环境中有效化合物的清洁验证。

Development of an automated and High throughput UHPLC/MS based workflow for cleaning verification of potent compounds in the pharmaceutical manufacturing environment.

机构信息

Analytical Science, Merck & Co., Inc., Rahway, New Jersey 07065, United States.

Analytical Science, Merck & Co., Inc., Rahway, New Jersey 07065, United States.

出版信息

J Pharm Biomed Anal. 2020 Sep 5;188:113401. doi: 10.1016/j.jpba.2020.113401. Epub 2020 Jun 4.

DOI:10.1016/j.jpba.2020.113401
PMID:32563056
Abstract

Cleaning verification (CV) is a critical step in the pharmaceutical manufacturing process to eliminate or reduce unacceptable contamination of a product as a result of insufficiently cleaned equipment surfaces. The main concern is cross contamination with active pharmaceutical ingredients (APIs) from previous runs that may impact patient safety. Current conventional approaches involve rather tedious sample preparation and analytical methods with relative lengthy analysis time. Potent APIs possessing low acceptable daily intake (ADI) values require analytical methods for CV with very low detection limits to confirm that these APIs are below their acceptance limits prior to the next manufacturing process. In this work, a novel end to end CV workflow was developed, which includes the automated sample and calibration solution preparation as well as high throughput analysis by ultra-high-performance liquid chromatography (UHPLC) coupled with single quadrupole mass spectrometry in multiple injection chromatography and selected ion monitoring mode (MIC-MS-SIM). The method was validated using ten model compounds. Acceptable specificity, linearity (R > 0.997) and single digit ng/mL LOQ and LOD were achieved for all model compounds. This approach was also successfully applied to the analysis of 22 internal CV samples from an internal program.

摘要

清洁验证 (CV) 是制药生产过程中的一个关键步骤,旨在消除或减少因设备表面清洁不彻底而导致产品受到不可接受的污染。主要关注点是来自先前批次的活性药物成分 (API) 的交叉污染,这可能会影响患者安全。目前的常规方法涉及到相当繁琐的样品制备和分析方法,分析时间相对较长。具有低可接受日摄入量 (ADI) 值的有效 API 需要具有非常低检测限的 CV 分析方法,以确认在下一次生产工艺之前,这些 API 低于其可接受限度。在这项工作中,开发了一种新颖的端到端 CV 工作流程,其中包括自动化的样品和校准溶液制备以及通过超高效液相色谱 (UHPLC) 与多注入色谱和选择离子监测模式 (MIC-MS-SIM) 结合进行高通量分析。该方法使用十种模型化合物进行了验证。所有模型化合物均达到了可接受的特异性、线性 (R > 0.997) 以及单个数字 ng/mL 的 LOQ 和 LOD。该方法还成功地应用于内部计划中 22 个内部 CV 样品的分析。

相似文献

1
Development of an automated and High throughput UHPLC/MS based workflow for cleaning verification of potent compounds in the pharmaceutical manufacturing environment.开发一种自动化和高通量的 UHPLC/MS 工作流程,用于药物制造环境中有效化合物的清洁验证。
J Pharm Biomed Anal. 2020 Sep 5;188:113401. doi: 10.1016/j.jpba.2020.113401. Epub 2020 Jun 4.
2
Cleaning validation of ofloxacin on pharmaceutical manufacturing equipment and validation of desired HPLC method.制药生产设备上氧氟沙星的清洁验证及所需高效液相色谱法的验证。
PDA J Pharm Sci Technol. 2008 Sep-Oct;62(5):353-61.
3
Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.筛查合成 PDE-5 抑制剂及其类似物作为掺杂物:分析技术和挑战。
J Pharm Biomed Anal. 2014 Jan;87:176-90. doi: 10.1016/j.jpba.2013.04.037. Epub 2013 May 6.
4
Preventing Cross-Contamination during Lyophilization: GMP and Occupational Cleaning Requirements for Nonproduct and Indirect Product-Contact Parts.冻干过程中的交叉污染预防:非产品和间接产品接触部件的GMP及职业清洁要求
PDA J Pharm Sci Technol. 2019 Sep-Oct;73(5):487-495. doi: 10.5731/pdajpst.2018.009530. Epub 2019 Aug 16.
5
Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.LC-MS/MS 法进行免疫抑制剂治疗药物监测:通过自动化处理全血样本优化工作流程。
Clin Biochem. 2013 Nov;46(16-17):1723-7. doi: 10.1016/j.clinbiochem.2013.08.013. Epub 2013 Sep 5.
6
An automated sample preparation approach for routine liquid chromatography tandem-mass spectrometry measurement of the alcohol biomarkers phosphatidylethanol 16:0/18:1, 16:0/16:0 and 18:1/18:1.一种自动化的样本制备方法,用于常规的液相色谱串联质谱法测量醇类生物标志物磷脂酰乙醇 16:0/18:1、16:0/16:0 和 18:1/18:1。
J Chromatogr A. 2019 Mar 29;1589:1-9. doi: 10.1016/j.chroma.2018.12.048. Epub 2018 Dec 21.
7
Evaluation of LC-MS for the analysis of cleaning verification samples.用于清洁验证样品分析的液相色谱-质谱联用技术评估
J Pharm Biomed Anal. 2006 Feb 24;40(3):631-8. doi: 10.1016/j.jpba.2005.10.026. Epub 2005 Nov 28.
8
Ultra high performance liquid chromatography-time-of-flight high resolution mass spectrometry in the analysis of hexabromocyclododecane diastereomers: method development and comparative evaluation versus ultra high performance liquid chromatography coupled to Orbitrap high resolution mass spectrometry and triple quadrupole tandem mass spectrometry.超高效液相色谱-飞行时间高分辨率质谱法分析六溴环十二烷非对映异构体:方法开发及与超高效液相色谱联用轨道阱高分辨率质谱法和三重四极杆串联质谱法的比较评估
J Chromatogr A. 2014 Oct 31;1366:73-83. doi: 10.1016/j.chroma.2014.09.021. Epub 2014 Sep 21.
9
Quantitative determination of residual active pharmaceutical ingredients and intermediates on equipment surfaces by ion mobility spectrometry.离子淌度谱法定量测定设备表面残留的活性药物成分和中间体。
J Pharm Biomed Anal. 2010 Jan 5;51(1):107-13. doi: 10.1016/j.jpba.2009.08.016. Epub 2009 Aug 18.
10
Improved liquid-liquid extraction with inter-well volume replacement dilution workflow and its application to quantify BMS-927711 in rat dried blood spots by UHPLC-MS/MS.改进的井间体积置换稀释液-液萃取工作流程及其在 UHPLC-MS/MS 定量测定大鼠干血斑中 BMS-927711 中的应用。
J Pharm Biomed Anal. 2014 Feb;89:240-50. doi: 10.1016/j.jpba.2013.11.017. Epub 2013 Nov 19.

引用本文的文献

1
Experimental design of a film flow cleaning rig equipped with in-line process analytical technology (PAT) tool for real-time monitoring.配备在线过程分析技术(PAT)工具以进行实时监测的薄膜流动清洁装置的实验设计。
Heliyon. 2024 Jul 16;10(15):e34679. doi: 10.1016/j.heliyon.2024.e34679. eCollection 2024 Aug 15.